Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle

scientific article published on 24 October 2009

Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ANTIVIRAL.2009.10.009
P698PubMed publication ID19857522
P5875ResearchGate publication ID38036862

P50authorErik De ClercqQ13578863
Christophe PannecouqueQ50551511
Dirk DaelemansQ50777234
P2093author name stringBrigitte Rosenwirth
Jean-Maurice Dumont
P2860cites workHIV reproducibly establishes a latent infection after acute infection of T cells in vitro.Q34985945
P433issue2
P304page(s)418-421
P577publication date2009-10-24
P1433published inAntiviral ResearchQ4775352
P1476titleDebio-025 inhibits HIV-1 by interfering with an early event in the replication cycle
P478volume85

Reverse relations

cites work (P2860)
Q28537731Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses
Q36993953Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms
Q26828727Curing a viral infection by targeting the host: the example of cyclophilin inhibitors
Q38061056Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms
Q24614498HIV type 1 Gag as a target for antiviral therapy
Q55280981Host-targeting therapies for hepatitis C virus infection: current developments and future applications.
Q30317509Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
Q38035344Recent advances targeting innate immunity-mediated therapies against HIV-1 infection.

Search more.